Pipeline Strategy – (Late Phase Development)

• Provide medical leadership for Phase 2 readout and Phase 3 readiness
• Develop early and evolving scientific narratives to position pipeline compound(s) within the orexin class and broader sleep landscape by closely working with clinical development team
• Contribute to Phase 3 clinical development plans, including:
  • Endpoint relevance and differentiation strategy
  • Patient segmentation and unmet need positioning
• Support internal decision-making through robust scientific interpretation of data

External Scientific Leadership & KOL Engagement

• Identify, map, and develop relationships with global and regional sleep disorder KOLs
• Lead and support Scientific exchange activities, advisory boards, Congress strategy and engagement
• Ensure the organization is seen as a credible scientific leader in sleep disorders and orexin biology

Competitive Intelligence & Insights

• Monitor and synthesize competitive landscape developments, including:
  • Other orexin antagonists and agonists
  • Emerging mechanisms in sleep disorders
• Translate insights into:
  • Strategic recommendations
  • Differentiation opportunities for both assets
• Collaborate cross-functionally to ensure consistent competitive positioning

Qualifications:

• PhD, MD, or PharmD with 5+ years of relevant experience. Experience in Life Sciences industry preferred.
• Advanced degree in sciences or related field with substantial experience in the pharma/biotech industry.
• OR a combination of equivalent education, deep subject matter expertise in sleep disorders along with a broad overall experience.
• Demonstrated experience in:
  • Global medical roles with cross-regional responsibility
  • Product launch and lifecycle management
  • Late-phase development (Phase 2/3 involvement)
• Prior experience in sleep disorders or orexin biology strongly preferred
• Ability to translate complex scientific outputs into strategic recommendations in collaboration with clinical development/operation team as well as global value & access team.
• Excellent communication and presentation skills
• Demonstrated success in engaging external experts (KOLs)
• Proven ability to lead in complex, matrixed, multinational environments with diverse stakeholders.
• Deep understanding of the drug development lifecycle, evidence generation, and Medical Affairs governance.
• Practical knowledge of FDA regulations/ICH guidelines regarding conduct of clinical studies in relevant therapeutic areas.

Final pay determinations will depend on various factors including but not limited to experience level, education, knowledge, and skills.

Employees are eligible to participate in Company employee benefit programs. For additional information on Company employee benefits programs, visit .

Certain other benefits may be available for this position, please discuss any questions with your recruiter.

Eisai is an equal opportunity employer and as such, is committed in policy and in practice to recruit, hire, train, and promote in all job qualifications without regard to race, color, religion, gender, age, national origin, citizenship status, marital status, sexual orientation, gender identity, disability or veteran status.Similarly, considering the need for reasonable accommodations, Eisai prohibits discrimination against persons because of disability, including disabled veterans.

Eisai Inc. participates in E-Verify. E-Verify is an Internet based system operated by the Department of Homeland Security in partnership with the Social Security Administration that allows participating employers to electronically verify the employment eligibility of all new hires in the United States. Please click on the following link for more information:

Right To Work

E-Verify Participation

Originally posted on Himalayas